Patent · US Active

Administration of FGF9 for treatment of anxiety

US9486499B2 · kind B2 · utility

0Cited by
4References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 25, 2013
Grant dateNov 8, 2016
Priority date
Expiry dateMay 14, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/304
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods for diagnosing mental disorders. The invention also provides methods of identifying modulators of mental disorders as well as methods of using these modulators to treat patients suffering from mental disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.